Hanne Vibeke Hansen Marquart

Medicine & Life Sciences

1. Agammaglobulinemia 15%
2. Allogeneic Cells 31%
3. Alternative Complement Pathway 41%
4. Antigen-Antibody Complex 23%
5. B-Lymphocytes 100%
6. Binding Sites 15%
7. Blood Cells 21%
8. Bovine Serum Albumin 16%
9. Cell Transplantation 48%
10. Cerebrospinal Fluid 25%
11. Child 25%
12. Chimerism 27%
13. Complement 3d Receptors 60%
14. Complement Activation 25%
15. complement C3d,g 16%
16. Complement Membrane Attack Complex 60%
17. Complement Receptors 59%
18. Erythrocytes 26%
19. Griscelli syndrome type 2 42%
20. Hematology 23%
21. Hemophagocytic Lymphohistiocytosis 29%
22. IgA Deficiency 32%
23. Interleukin-12 Receptors 36%
24. Klinefelter Syndrome 30%
25. Leukemia 40%
26. Leukocytes 19%
27. Lymphocytes 15%
28. Lymphoma, Large B-Cell, Diffuse 16%
29. Lymphopenia 27%
30. Mercaptopurine 29%
31. Monocytes 18%
32. Multiple Sclerosis 19%
33. Mycobacterium 24%
34. Myositis 27%
35. Otitis Media 24%
36. Pediatrics 21%
37. Phenotype 15%
38. Pigmentary Dilution 15%
39. Pneumonia 17%
40. PR-SET Domains 22%
41. Precursor Cell Lymphoblastic Leukemia-Lymphoma 78%
42. Properdin 34%
43. Randomized Controlled Trials 15%
44. Recurrence 25%
45. Relapsing-Remitting Multiple Sclerosis 19%
46. Residual Neoplasm 25%
47. Systemic Lupus Erythematosus 20%
48. Therapeutics 16%
49. Thymoma 26%